Repinirast (INN; marketed under the tradename Romet) is an antihistamine.[1][2]

Repirinast
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 3-methylbutyl 7,8-dimethyl-4,5-dioxo-5,6-dihydro-4H-pyrano[3,2-c]quinoline-2-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H21NO5
Molar mass355.390 g·mol−1
3D model (JSmol)
  • CC1=C(C2=C(C=C1)C3=C(C(=O)C=C(O3)C(=O)OCCC(C)C)C(=O)N2)C
  • InChI=1S/C20H21NO5/c1-10(2)7-8-25-20(24)15-9-14(22)16-18(26-15)13-6-5-11(3)12(4)17(13)21-19(16)23/h5-6,9-10H,7-8H2,1-4H3,(H,21,23) ☒N
  • Key:NFQIAEMCQGTTIR-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

References

edit
  1. ^ Yamada N, Ohgaki M, Muramatsu M (1993). "Repirinast inhibits antigen-induced early and late pulmonary responses and airway hyperresponsiveness in guinea pigs". International Archives of Allergy and Immunology. 100 (4): 367–72. doi:10.1159/000236440. PMID 8386963.
  2. ^ Yamada N, Kadowaki S, Takahashi K, Umezu K (September 1992). "MY-1250, a major metabolite of the anti-allergic drug repirinast, induces phosphorylation of a 78-kDa protein in rat mast cells". Biochemical Pharmacology. 44 (6): 1211–3. doi:10.1016/0006-2952(92)90387-x. PMID 1358073.
edit